RA Capital Management - KALVISTA PHARMACEUTICALS INC ownership

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 93 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
RA Capital Management ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$28,453,000
+11.4%
1,930,3220.0%0.62%
+38.0%
Q4 2021$25,538,000
-24.2%
1,930,3220.0%0.45%
-3.6%
Q3 2021$33,684,000
-27.2%
1,930,3220.0%0.47%
-37.1%
Q2 2021$46,251,000
+414.4%
1,930,322
+451.5%
0.74%
+445.6%
Q1 2021$8,992,000
-78.2%
350,000
-75.7%
0.14%
-92.4%
Q1 2019$41,243,000
+44.9%
1,441,0700.0%1.78%
+7.3%
Q4 2018$28,461,000
-10.7%
1,441,0700.0%1.66%
-2.7%
Q3 2018$31,862,000
+172.3%
1,441,0700.0%1.70%
+124.1%
Q2 2018$11,701,000
-14.3%
1,441,0700.0%0.76%
-27.4%
Q1 2018$13,661,000
-2.8%
1,441,0700.0%1.05%
-11.0%
Q4 2017$14,050,000
+223.0%
1,441,070
+143.8%
1.18%
+199.2%
Q3 2017$4,350,0000.0%591,0700.0%0.39%
-21.2%
Q2 2017$4,350,000
-5.8%
591,0700.0%0.50%
-11.8%
Q1 2017$4,616,000
+10.5%
591,0700.0%0.57%
-4.4%
Q4 2016$4,179,000591,0700.59%
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Saturn V Capital Management LP 719,937$6,697,4595.56%
TCG Crossover Management, LLC 3,395,495$22,953,5464.05%
VR Adviser, LLC 2,916,667$19,716,6693.32%
TANG CAPITAL MANAGEMENT LLC 3,196,446$21,607,9753.14%
Prosight Management, LP 621,667$4,202,4692.29%
Opaleye Management Inc. 923,200$6,240,8322.17%
GREAT POINT PARTNERS LLC 1,055,801$7,137,2151.40%
Frazier Life Sciences Management, L.P. 3,238,859$21,894,6871.36%
DAFNA Capital Management LLC 616,032$4,164,3761.17%
Vivo Capital, LLC 856,008$5,7870.67%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders